PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX)

CUSIP: 729139105

Q3 2025 13F Holders as of 30 Sep 2025

Holder snapshot 7 signals
Share change
-912,470
Put/Call ratio
143%
SEC-reported price per share
$1.48
Number of holders
97
Value change
+$1,536,181
Number of buys
33
Open additional details 1 more signal available
Number of sells
68
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
61,907,011

Security key

729139105

Report period

Q3 2025

Institutions

97

Top holders

10

Ownership snapshot

Top reported holders of PLRX - PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
TANG CAPITAL MANAGEMENT LLC
Disclosed value leader
Third Rock Ventures III, ...
Comparable rows
6/15
Latest evidence
30 Jun 2025
13D/G 13F 3/4/5 Lead comparable stake: 9.6% 9 rows are not safely comparable across share classes. 13D/G row: TANG CAPITAL MANAGEMENT LLC Showing 1-6 of 15 holder rows.

Quick read

TANG CAPITAL MANAGEMENT LLC leads the comparable SEC ownership view at 9.6%.

6 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens TANG CAPITAL MANAGEMENT LLC's linked filing trail.
Comparable ownership Top 5
TANG CAPITAL MANAGEMENT LLC 9.6%
VANGUARD GROUP INC 4.9%
Redmile Group, LLC 4.8%
BlackRock, Inc. 3.4%
FMR LLC 0.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
TANG CAPITAL MANAGEMENT LLC
13D/G 13F
Company
9.6%
Reported 13D/G · 03 Mar 2025
$9,198,699
5,859,044 shares
$0 03 Mar 2025
VANGUARD GROUP INC
13F 13D/G
Company · The Vanguard Group
4.9%
Reported 13D/G · 30 Jun 2025
$3,482,724
3,002,348 shares
— 30 Jun 2025
Redmile Group, LLC
13D/G 13F
Company
4.8%
Reported 13D/G · 31 Dec 2024
$4,545,900
2,895,478 shares
$0 31 Dec 2024
BlackRock, Inc.
13F 13D/G
Company
3.4%
Reported 13D/G · 30 Jun 2025
$2,471,401
2,130,519 shares
— 30 Jun 2025
FMR LLC
13D/G
0.2%
Reported 13D/G · 28 Feb 2025
$207,230
131,993 shares
$0 28 Feb 2025
PRICE T ROWE ASSOCIATES INC /MD/
13D/G 13F
T. Rowe Price Associates, Inc. · Company
0.1%
Reported 13D/G · 31 Mar 2025
$137,648
87,674 shares
$0 31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
97
Shares
50,406,732
Rows available
97
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
112
Q3 2025 holders
97
Holder diff
-15
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 value Q3 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .